MedPath

The investigation study on endogenous amino acids and amino acid derivatives changes following exercise.

Not Applicable
Conditions
Healthy subjects
Registration Number
JPRN-UMIN000052868
Lead Sponsor
Pharma Foods International,Co.Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
Male
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

1.Individuals currently undergoing medication or outpatient treatment for any serious illness. 2.Individuals currently undergoing exercise or dietary therapy under medical supervision. 3. Individuals with current or past history of substance dependence or alcohol dependence. 4.Individuals currently undergoing outpatient treatment for mental disorders (such as depression) or sleep disorders, or with a history of past mental health disorders. 5.Individuals with irregular lifestyle rhythms due to night shifts or shift work. 6.Individuals with extremely irregular habits in diet, sleep, and other lifestyle factors. 7.Individuals practicing extreme dietary restrictions. 8.Individuals with a history of or current serious diseases, such as brain disorders, malignant tumors, immune disorders, diabetes, liver diseases (hepatitis), kidney diseases, heart diseases, thyroid disorders, adrenal disorders, and other serious metabolic disorders. 9. Individuals regularly consuming supplements containing GABA. 10.Individuals who have participated in another clinical trial (study) within the past 3 months from the date of consent or have plans to participate in another clinical trial (study) during the trial period. 11. Individuals who have donated blood or blood components exceeding 200 mL within the past 1 month or 400 mL within the past 3 months from the date of consent. 12. Individuals who find it difficult to comply with the recording requirements of various survey forms. 13. Any other individuals deemed unsuitable as participants by the trial coordinator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
(Metabolic responses to exercise) 1.Amino acids 2.Lactate 3.Amino acid derivatives * Examine time-course metabolomic changes in blood before and after exercise trials (0,60,120,180 min) * For the endurance exercise trial, blood collection will take place before exercise, 30 minutes during the exercise, and at 0, 60, 120, and 180 min after exercise.
Secondary Outcome Measures
NameTimeMethod
1.Physical measurement 2.Vital signs(Blood pressure/heart rate) *During endurance exercise trial, real time heart rate is monitored for maintaining 60% heart reserve rate.
© Copyright 2025. All Rights Reserved by MedPath